Abstract
Drug photosensitivity is a relatively frequent adverse event, although not always recognized due to its clinical polymorphism and difficulties in performing tests to prove drug causality.
In this chapter the authors review the mechanisms of photosensitivity related with topical and systemic drug exposure (phototoxicity, photoallergy, autoimmunity, and enhanced photocarcinogenesis), the main acute and delayed clinical manifestations (acute sunburn or eczema, pseudoporphyria, photoonycholysis, dyschromia, telangiectasia, subacute lupus erythematosus, pre-cancerous lesions, and cutaneous neoplasia), the main culprits (NSAIDs, antimicrobials, like fluorquinolones and tetracyclines, psychotropic, anticancer, and cardiovascular drugs), and the most adequate diagnostic procedures (photopatch and drug photoprovocation tests).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adachi T, Satou Y, Satou H, Shibata H, Miwa S, Iwase Y, et al. Assessment of 8-methosypsoralen, lomefloxacin, sparfloxacin, and pirfenidone phototoxicity in long-evans rats. Int J Toxicol. 2015;34:16–23.
Agúndez JAG, García-Martín E, García-Lainez G, Miranda MA, Andreu I. Photomutagenicity of chlorpromazine and its N-demethylated metabolites assessed by NGS. Sci Rep. 2020;10:1–6.
Almebayadh M, Regnier-Rosencher E, Carlotti A, Goulvestre C, Le Guern V, Mouthon L, et al. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors. Dermatology. 2013;226:119–23.
Alrashidi A, Rhodes LE, Ahad DFT, Sharif JCH, Kreeshan FC. Systemic drug photosensitivity—culprits , impact and investigation in 122 patients. Photodermatol Photoimmunol Photomed. 2020;36:1–11.
Amelot A, Dupouy-Camet J, Jeanmougin M. Phototoxic reaction associated with malarone (atovaquone/proguanil) antimalarial prophylaxis. J Dermatol. 2014;41:346–8.
Ammoury A, Michaud S, Paul C, Prost-Squarcioni C, Alvarez F, Lamani L, et al. Photodistribution of blue-gray hyperpigmentation after amiodarone treatment. Molecular characterization of amiodarone in the skin. Arch Dermatol. 2008;144:92–6.
Arias-Santiago S, Fernandéz-Pugnaire M, Anamzán-Fernandéz F, Serrano-Franco C, Serrano-Ortega S. Phytophotodermatitis due to ruta graveolens prescribedfor fibromyalgia. Rheumatology (Oxford). 2009;48:1401.
Armstrong RB, Leach EE, Whitman G, Harber LC, Poh-Fitzpatrick MB. Quinidine photosensitivity. Arch Dermatol. 1985;121:525.
Asensio T, Sanchis M, Sánchez P, Vega J, Garcia J. Photocontact dermatitis because of oral dexketoprofen. Contact Dermatitis. 2008;58:59–60.
Auffret N, Janssen F, Chevalier P, Guillemain R, Amrein C, Le Beller C. Photosensibilisation au voriconazole. Ann Dermatol Vénéreol. 2006;133:330–2.
Avenel-Audrun M, Dulartre H, Goossens A, Jeanmougin M, Comte C, Bernier C, et al. Octocrylene, an emerging photoallergen. Arch Dermatol. 2010;146:753–7.
Baran R, Juhlin L. Photoonycholysis. Photodermatol Photoimmunol Photomed. 2002;18:202–7.
Barbaud A, Collet E, Martin S, Granel F, Tréchot P, Lambert D, et al. Contact sensitization to chlorproéthazine can induce persistent light reaction and cross photoreactions to other phenothiazines. Contact Dermatitis. 2001a;44:373.
Barbaud A, Gonçalo M, Bircher A, Bruynzeel D. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001b;45:321–8.
Batrani M, Salhotra M, Kubba A, Agrawal M. Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia. Indian J Dermatol Venereol Leprol. 2016;82:727.
Béani J. Les photosensibilisations graves. Ann Dermatol Venereol. 2009;136:76–83.
Berghoff A, English J. Imatinib mesylate-induced pseudoporphyria. J Am Acad Dermatol. 2010;63:e14–6.
Biazar C, Sigges J, Patsinakidis N, Ruland V, Amler S, Bonsmann G, et al. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev. 2013;12:444–54.
Bibas N, Sartor V, Bulai Livideanu C, Bagheri H, Nougué J, Giordano-Labadie F, et al. Contact photoallergy to isothipendyl chlorhydrate. Dermatology. 2012;224:289–91.
Bilu D, Mamelak A, Nguyen R, Queiroz P, Kowalski J, Morison W, et al. Clinical and epidemiologic characterization of photosensitivity in HIV-positive individuals. Photodermatol Photoimmunol Photomed. 2004;20:175–83.
Birkett DA, Garretts M, Stevenson CJ. Phototoxic bullous eruptions due to nalidixic acid. Br J Dermatol. 1969;81:342–4.
Blakely KM, Drucker AM, Rosen CF. Drug-induced photosensitivity—an update: culprit drugs, prevention and management. Drug Saf. 2019;42:827–47.
Boisvert A, Barbeau G. Nalidixic acid-induced photodermatitis after minimal sun exposure. Drug Intell Clin Pharm. 1981;15:126.
Bonamonte D, Foti C, Lionetti N, Rigano L, Angelini G. Photoallergic contact dermatitis to 8-MOP in Ficus carica. Contact Dermatitis. 2010;62:343–8.
Borgia F, Vaccaro M, Guarneri F, Cannavo SP. Photodistributed telangiectasia following use of cefotaxime. Br J Dermatol. 2000;143:674–5.
Boudewijns S, Gerritsen WR, Koornstra RHT. Indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma. BMC Cancer. 2014;14:1–4.
Brugière C, Stefan A, Morice C, Cornet E, Moreau A, Allouche S, et al. Vemurafenib skin phototoxicity is indirectly linked to ultraviolet a minimal erythema dose decrease. Br J Dermatol. 2014;171:1529–32.
Bruynzeel DP, Ferguson J, Andersen K, Gonçalo M, English J, Goossens A, et al. Photopatch testing: a consensus methodology for Europe. J Eur Acad Dermatol Venereol. 2004;18:679.
Canelas MM, Cardoso JC, Gonçalo M, Figueiredo A. Photoallergic contact dermatitis from benzydamine presenting mainly as lip dermatitis. Contact Dermatitis. 2010;63:85–8.
Cardoso JC, Canelas MM, Gonçalo M, Figueiredo A. Photopatch testing with an extended series of photoallergens: a 5-year study. Contact Dermatitis. 2009;60:325–9.
Caro-Gutierrez D, Floristan Muruzabal MU, Gomez Fuente E, Franco AP, Lopez Estebaranz JL. Photo-induced erythema multiforme associated with vandetanib administration. J Am Acad Dermatol. 2014;71:e142–4.
Chandler MJ. Recurrence of phototoxic skin eruption due to trimethoprim. J Infect Dis. 1986;153:1001.
Chang C-HH, Chang JWC, Hui C-YY, Yang C-HH. Severe photosensitivity reaction to vandetanib. J Clin Oncol. 2009;27:e114–5.
Chen M, Crowson A, Woofter M, Luca M, Magro C. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J Rheumatol. 2004;31:818–20.
Cirne de Castro J, Freitas J, Brandão F, Themido R. Sensitivity to thimerosal and photosensitivity to piroxicam. Contact Dermatitis. 1991;24:187–92.
Collins P, Ferguson J. Photodistributed nifedipine-induced facial telangiectasia. Br J Dermatol. 1993;129:630.
Connors T, Restrepo A, Dao H Jr. Brown-gray hyperpigmentation in a photosensitive distribution after levofloxacin exposure. Dermatol Online J. 2018;24:0–5.
Conti R, Bassi A, Difonzo EM, Moretti S, Francalanci S. A case of photoallergic contact dermatitis caused by unusual exposure to ketoprofen. Dermatitis. 2012;23:295–6.
Correia O, Delgado L, Barros M. Bullous photodermatosis after lomefloxacin. Arch Dermatol. 1994;130:808–9.
Cowen E, Nguyen J, Miller D, Mcshane D, Arron S, Prose N, et al. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol. 2010;62:31–7.
Cummins R, Wagner-Weiner L, Paller A. Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis. J Rheumatol. 2000;27:2938–40.
Dam C, Bygum A. Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. Acta Derm Venereol. 2008;88:87–9.
Dawe R, Ibbotson S. Drug-induced photosensitivity. Dermatol Clin. 2014;32:363–8.
Dawson TA. Quinine lichenoid photosensitivity. Clin Exp Dermatol. 1986;11:670–1.
De Guidi G, Bracchitta G, Catalfo A, Doria VA, Chimiche S. Photosensitization reactions of fluoroquinolones and their biological consequences. Photochem Photobiol. 2011;87:1214–29.
Delaunay J, Chassain K, Sarre M, Avenel-audran M. A drug not recognised as a photosensitiser? Contact Dermatitis. 2019;81(2):143–4.
Devleeschouwer V, Roelandts R, Garmyn M, Goossens A. Allergic and photoallergic contact dermatitis from ketoprofen: results of (photo) patch testing and follow-up of 42 patients. Contact Dermatitis. 2008;58:159–66.
Dummer R, Rinderknecht J, Goldinger S. Ultraviolet a and photosensitivity during vemurafenib therapy. N Engl J Med. 2012;366:480–1.
Elkeeb D, Elkeeb L, Maibach H. Photosensitivity: a current biological overview. Cutan Ocul Toxicol. 2012;31:263–72.
EMCPPTS Taskforce, Kerr A, Ferguson J, Haylett A, Rhodes L, Adamski H, et al. A European multicentre photopatch test study. Br J Dermatol. 2012;166:1002–9.
Emmert B, Schauder S, Palm H, Haliier E, Emmert S. Disabling work-related persistent photosensitivity following photoallergic contact dermatitis from chlorpromazine and olaquindox in a pig breeder. Ann Agric Environ Med. 2007;14:329.
Epaulard O, Villier C, Ravaud P, Chosidow O, Blanche S, Mamzer-Bruneel MF, et al. A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study. Clin Infect Dis. 2013;57:182–8.
Farhi D, Viguier M, Cosnes A, Reygagne P, Dubertret L, Revuz J, et al. Terbinafine-induced subacute cutaneous lupus erythematosus. Dermatology. 2006;212:59–65.
Ferguson J. Drug and chemical photosensitivity. New York, NY: Oxford University Press; 1999. p. 155–69.
Ferguson J, Addo H, Jones S, Johnson B, Frain-Bell W. A study of cutaneous photosensitivity induced by amiodarone. Br J Dermatol. 1985;113:537–49.
Fernández-Jorge B, Buján J, Paradela S, Mazaira M, Fonseca E. Consort contact dermatitis from piketoprofen. Contact Dermatitis. 2008;58:113–5.
Fernández-Jorge B, Goday-Buján J, Murga MF, Pérez-Varela L, Fonseca E. Photoallergic contact dermatitis due to diclofenac with cross-reaction to aceclofenac: two case reports. Contact Dermatitis. 2009;61:236–7.
Ferrer-Guillén B, Giácaman MM, Valenzuela Oñate C, Magdaleno Tapial J, Hernández Bel P, Pérez FA. Pirfenidone-induced photosensitivity confirmed by pathological phototest. Photodiagnosis Photodyn Ther. 2019;25:103–5.
Figueiredo A. Fotossensibilidade aos anti-inflamatórios não esteróides. Estudo fisiopatológico (Thesis). Coimbra: University of Coimbra; 1994.
Foti C, Bonamonte D, Conserva A, Stingeni L, Lisi P, Lionetti N, et al. Allergic and photoallergic contact dermatitis from ketoprofen: evaluation of cross-reactivities by a combination of photopatch testing and computerized conformational analysis. Curr Pharm Des. 2008;14:2833–9.
Frenard C, Dutartre H, Boisrobert A, Khammari A, Dreno B. Decreased photosensitivity to UVA on vemurafenib combined with cobimetinib. J EADV. 2019;33:e87–8.
Frick M, Soler-Palacin P, Nalda A, Guarmer M, Nadal C. Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole. Pediatr Infect Dis J. 2010;29:480–1.
Frisch S, Askari S, Beaty S, Burkemper C. X-linked chronic granulomatous disease with voriconazole-induced photosensitivity/photoaging reaction. J Drugs Dermatol. 2010;9:562–4.
Fujimoto N, Danno K, Wakabayashi M, Uenishi T, Tanaka T. Photosensitivity with eosinophilia due to ambroxol and UVB. Contact Dermatitis. 2009;60:110–3.
Fukai T, Hasegawa T, Nagata A, Matsumura M, Kudo Y, Shiraishi E, et al. Case of erlotinib-induced photosensitivity. J Dermatol. 2014;41:445–6.
Gaikwad RP, Mukherjee SS. Pirfenidone induced phototoxic reaction in an elderly man. Indian J Dermatol Venereol Leprol. 2016;82:101–3.
Gelot P, Dutartre H, Khammari A, Boisrobert A, Schmitt C, Deybach J, et al. Vemurafenib: an unusual UVA-induced photosensitivity. Exp Dermatol. 2013;22:297–8.
Giacchero D, Ramacciotti C, Arnault J, Brassard M, Baudin E, Maksimovic L, et al. A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib. Arch Dermatol. 2012;148:2012–4.
Gómez-Bernal S, Álvarez-Pérez A, Rodríguez-Pazos L, Gutiérrez-González E, Rodríguez-Granados MT, Toribio J. Fotosensibilidad por tiazidas. Actas Dermosifiliogr. 2014;105:359–66.
Gonçalo M. Photopatch testing. In: Johanssen J-D, Frosch P, Lepittevin J-P, editors. Contact dermatitis. Berlin-Heidelberg: Springer-Verlag; 2011. p. 519–32.
Gonçalo M. Phototoxic dermatitis. In: Rustemeyer T, Elsner P, John S-M, Maibach HI, editors. Kanerva’s occupational dermatology. Berlin, Heidelberg: Springer; 2012. p. 147–60.
Gonçalo M. Phototoxic dermatitis. In: John S, Johansen JD, Rustemeyer T, Elsner P, Maibach HI, editors. Kanerva’s occupational dermatology. Cham: Springer International Publishing AG; 2018.
Gonçalo M. Photopatch testing. In: Johansen JD, Mahler V, Lepoittevin J-P, Frosch P, editors. Contact dermatitis. Cham: Springer, Nature; 2019.
Gonçalo M. Phototoxic and photoallergic reactions. In: Johansen J, Frosch P, Lepoittevin J, editors. Contact dermatitis. Cham: Springer International Publishing; 2020.
Gonçalo M, Figueiredo A. Photopatch testing with nonsteroidal anti-inflammatory drugs. In: Proceedings of the 1st European symposium of contact dermatitis. Brussels; 1992. p. 25.
Gonçalo M. Explorations dans les photo-allergies médicamenteuses. In: GERDA, editor. Progrès en dermato-allergologie. Nancy: John Libbey Eurotext; 1998. p. 67–74.
Gonçalo M, Giménez-Arnau A. Drug photosensitivity. In: Katsambas AD, Lotti TM, Dessinioti C, D’Erme AM, editors. European handbook of dermatological treatments. Berlin: Springer-Verlag; 2015. p. 233–51.
Gonçalo M, Figueiredo A, Tavares P, Fontes Ribeiro C, Teixeira F, Poiares Baptista A. Photosensitivity to piroxicam: absence of cross reaction with tenoxicam. Contact Dermatitis. 1992;27:287–90.
Gonçalo M, Ruas E, Figueiredo A, Gonçalo S. Contact and photocontact sensitivity to sunscreens. Contact Dermatitis. 1995;33:278–80.
Gonçalo M, Figueiredo A, Gonçalo S. Hypersensitivity to thimerosal: the sensitizing moiety. Contact Dermatitis. 1996a;34:201–3.
Gonçalo M, Barros M, Azenha A, Bastos S, Figueiredo A. The importance of photopatch testing in patients with photosensitive drug eruptions. J EADV. 1996b;7:s20.
Gonçalo M, Domingues J, Correia O, Figueiredo A. Fotossensibilidad a flutamida. Bol Inf del GEIDC. 1999;29:45–8.
Gonçalo M, Oliveira HSH, Fernandes B, Robalo-Cordeiro M, Figueiredo A. Topical provocation in fixed drug eruption from nonsteroidal anti-inflammatory drugs. Exog Dermatol. 2002;1:81–6.
Gonçalo M, Ferguson J, Bonevalle A, Bruynzeel DP, Giménez-Arnau A, Goossens A, et al. Photopatch testing: recommendations for a European photopatch test baseline series. Contact Dermatitis. 2013;68:239–43.
Goyal RK. Voriconazole-associated phototoxic dermatoses and skin cancer. Expert Rev Anti Infect Ther. 2015;13:1537–46.
Grabczynska SA, Cowley N. Amlodipine induced-photosensitivity presenting as telangiectasia. Br J Dermatol. 2000;142:1255.
Gregoriou S, Karagiorga T, Stratigos A, Volonakis K, Kontochristopoulos G, Rigopoulos D. Photo-onycholysis caused by olanzapine and aripiprazole. J Clin Psychopharmacol. 2008;28:219–20.
Grönhagen C, Fored C, Linder M, Granath F, Nyberg F. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden. Br J Dermatol. 2012;167:296–305.
Gutierrez-Gonzalez E, Rodriguez-Pazos L, Rodriguez-Granados MT, Toribio J, Gutiérrez-gonzález E, Rodríguez-pazos L, et al. Photosensitivity induced by naproxen. Photodermatol Photoimmunol Photomed. 2011;27:338–40.
Guy R, Kuma H, Nakanishi M. Serious photocontact dermatitis induced by topical ketoprofen depends on the formulation. Eur J Dermatol. 2014;24:365–71.
Hague JS, Ilchyshyn A. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer. Clin Exp Dermatol. 2007;32:102–3.
Hamada K, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S. Photosensitivity due to tocilizumab presenting with erythema multiforme-like lesions. Eur J Dermatol. 2016;26:503–4.
Hansford JR, Cole C, Blyth CC, Gottardo NG. Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy. J Antimicrob Chemother. 2012;67:1807–9.
Hariva T, Kitamura K, Osawa J, Ikezawa Z. A cross-reaction between piroxicam-photosensitivity and thiosalicylate hypersensitivity in lymphocyte proliferation test. J Dermatol Sci. 1993;5:165–74.
Hawk J. Photodermatology. 1st ed. New York, NY: Oxford University Press; 1999.
Hawk J. Chronic actinic dermatitis. Photodermatol Photoimmunol Photomed. 2004;20:312–4.
Hawk JL, Alvarez-Fernandez JG, Castano-Suarez E, Cornejo-Navarro P, Fuente EG, Ortiz Frutos FJ, et al. Photosensitivity induced by oral itraconazole. J Eur Acad Dermatol Venereol. 2000;14:445.
Haylett AK, Felton S, Denning DW, Rhodes LE. Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients. Br J Dermatol. 2013;168:179–85.
Hickman G, Duval A, Picard C, Petit A. Porphyrie cutanée tardive révélée par le voriconazole. Ann Dermatol Venereol. 2010;137:36–9.
Hindsén M, Isaksson M, Persson L, Zimersson E, Bruze M. Photoallergic contact dermatitis from ketoprofen induced by drug-contaminated personal objects. J Am Acad Dermatol. 2004;50:215–9.
Hindsén M, Zimerson E, Bruze M. Photoallergic contact dermatitis from ketoprofen in southern Sweden. Contact Dermatitis. 2006;54:150–7.
Hussain S, Anderson DN, Salvatti ME, Adamson B, McManus M, Braverman AS. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature. Cancer. 2000;88:2367–71.
Ikezawa Z, Kitamura K, Osawa J, Hariva T. Photosensitivity to piroxicam is induced by sensitization to thimerosal and thiosalicylate. J Invest Dermatol. 1992;98:918–20.
Imai S, Atarashi K, Ikesue K, Akiyama K, Tokura Y. Establishment of murine model of allergic photocontact dermatitis to ketoprofen and characterization of pathogenic T cells. J Dermatol Sci. 2005;41:127–36.
Infante Hernando L, Serra-Baldrich E, Dordal T, Puig SL. Photoallergic contact dermatitis caused by benzophenones in magazine inks. Contact Dermatitis. 2013;69:124–6.
Isaacs T, Ngwanya MR, Dlamini S, Lehloenya RJ. Annular erythema and photosensitivity as manifestations of efavirenz-induced cutaneous reactions: a review of five consecutive cases. J Antimicrob Chemother. 2013;68:2871–4.
Izu K, Hino R, Isoda H, Nakashima D, Kabashima K, Tokura Y. Photocontact dermatitis to ketoprofen presenting with erythema multiforme. Eur J Dermatol. 2008;18:710–3.
Jensen A, Thomsen H, Engebjerg M, Olesen A, Sorensen H, Karagas M. Use of photosensitising diuretics and risk of skin cancer: a population based case-control study. Br J Cancer. 2008;99:1522–8.
Jiang C, Huang H, Liu J, Wang Y, Lu Z, Xu Z. Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials. PloS One. 2012;7:e47024.
Johnston GA. Thiazide-induced lichenoid photosensitivity. Clin Exp Dermatol. 2002;27:670–2.
Joseph MS. Photodermatitis provoked by dapsone: a case report. Lepr Rev. 1987;58:425.
Karagas MR, Stukel TA, Umland V, Tsoukas MM, Mott LA, Sorensen HT, et al. Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study. J Invest Dermatol. 2007;127:2901–3.
Karimian-Teherani D, Kinaciyan T, Tanew A. Photoallergic contact dermatitis from heracleum giganteum. Photodermatol Photoimmunol Photomed. 2008;24:99–101.
Karlsson I, Vanden Broecke K, Martensson J, Goossens A, Borje A. Clinical and experimental studies of octocrylene’s allergenic potency. Contact Dermatitis. 2011;64:343–52.
Katsarou A, Makris M, Zarafonitis G, Lagogianni E, Gregoriou S, Kalogeromitros D. Photoallergic contact dermatitis:the 15-year experience of a tertiary reference center in a sunny mediterranean city. Int J Immunopathol Pharmacol. 2008;21:725–7.
Kawabe Y, Mizuno N, Miwa N, Sakakibara S. Photosensitivity induced by griseofulvin. Photodermatol. 1988;5:272.
Kerr A, Ferguson J, Ibbotson S. Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid photodynamic therapy. Clin Exp Dermatol. 2007;32:201–2.
Kerr A, Muller F, Ferguson J, Dawe R. Occupational carprofen photoallergic contact dermatitis. Br J Dermatol. 2008a;159:1303–8.
Kerr A, Woods J, Ferguson J. Photocontact allergic and phototoxicstudies of chlorproethazine. Photodermatol Photoimmunol Photomed. 2008b;24:11–5.
Kerr A, Becher G, Ibbotson S, Ferguson J. Action spectrum for etofenamate photoallergic contact dermatitis. Contact Dermatitis. 2011;65:117–8.
Khandpur S, Porter RM, Boulton SJ, Anstey A. Drug-induced photosensitivity: new insights into pathomechanisms and clinical variation through basic and applied science. Br J Dermatol. 2017;176:902–9.
Kiely C, Murphy G. Photoallergic contact dermatitis caused by occupational exposure to the canine non-steroidal anti-inflammatory drug carprofen. Contact Dermatitis. 2010;63:364–5.
Kimura M, Kawada A. Photosensitivity induced by lomefloxacin with cross-photosensitivity to ciprofloxacin and fleroxacin. Contact Dermatitis. 1998;38:180.
Klecak G, Urbach F, Urwyler H. Fluoroquinolone antibacterials enhance UVA-induced skin tumors. J Photochem Photobiol B. 1997;37:174–81.
Kosior DA. Cutaneous adverse reactions of amiodarone. Med Sci Monit. 2014;20:2369–72.
Kowalzick L, Ziegler H. Photoallergic contact dermatitis from topical diclofenac in solaraze gel. Contact Dermatitis. 2006;54:348–9.
Kurumajin Y, Shono M. Scarified photopatch testing in lomefloxacin photosensitivity. Contact Dermatitis. 1992;26:5–10.
Kutlubay Z, Sevim A, Engin B, Tüzün Y. Photodermatoses, including phototoxic and photoallergic reactions (internal and external). Clin Dermatol. 2014;32:73–9.
Kuwatsuka S, Kuwatsuka Y, Takenaka M, Utani A. Case of photosensitivity caused by fenofibrate after photosensitization to ketoprofen. J Dermatol. 2016;43:224–5.
Kuznetsov AV, Weisenseel P, Flaig MJ, Ruzicka T, Prinz JC. Photoallergic erythroderma due to doxycycline therapy of erythema chronicum migrans. Acta Derm Venereol. 2011;91:734–6.
La Cuadra-Oyanguren J, Pérez-Ferriols A, Lecha-Carralero M, Giménez-Arnau A, Fernández-Redondo V, Ortiz de Frutos F, et al. Results and assessment of photopatch testing in Spain: towards a new standard set of photoallergens. Actas Dermosifiliogr. 2007;98:96–101.
Lacouture M, Melasky D. Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: a dermatology:oncology perspective. Skin Therapy Lett. 2008;12:1–5.
Lamond NWD, Younis T, Purdy K, Dorreen MS. Drug-induced subacute cutaneous lupus erythematosus associated with nab-paclitaxel therapy. Curr Oncol. 2013;20:e484–7.
Lankerani L, Baron E. Photosensitivity to exogenous agents. J Cutan Med Surg. 2004;8:424–31.
Lasa Elgezua O, Gorrotxategi P, Gardeazabal Gracia J, Ratón Nieto J, Pérez J. Photoallergic hand eczema due to benzydamine. Eur J Dermatol. 2004;14:69–70.
LeCoz C, Bottlaender A, Scrivener J-N, Santinelli F, Cribier B, Heidei E, et al. Photocontact dermatitis from ketoprofen and tiaprofenic acid: cross-reactivity study in 12 consecutive patients. Contact Dermatitis. 1998;38:245–52.
Lee AY, Jung SY. Two patients with isoniazid-induced photosensitive lichenoid eruptions confirmed by photopatch test. Photodermatol Photoimmunol Photomed. 1998;14:77.
Lembo S, Raimondo A, Conti V, Venturini M. Photosensitivity and cancer immune-targeted therapies. Photodermatol Photoimmunol Photomed. 2020;36:172–8.
Lenfestey A, Friedmann D, Burke W. Metformin-induced pseudoporphyria. J Drugs Dermatol. 2012;11:1272.
Leonard F, Adamski H, Bonnevalle A, Bottlaender A, Bourrain J, Goujon-Henry G, et al. Étude prospective multicentrique 1991-2001 de la batterie standard des photopatch-tests de la Société Française de Photodermatologie. Ann Dermatol Vénéreol. 2005;132:313–20.
Leroy D, Dompmartin A, Szczurko C. Flutamide photosensitivity. Photodermatol Photoimmunol Photomed. 1996;12:216.
Levy ML, Barron KS, Eichenfield A, Honig PJ. Naproxen-induced pseudoporphyria: a distinctive photodermatitis. J Pediatr. 1990;117:660.
Lhiaubet-Vallet V, Bosca F, Miranda M. Photosensitized DNA damage: the case of fluoroquinolones. Photochem Photobiol. 2009;85:861–8.
Lisi P, Assalve D, Hansel K. Phototoxic and photoallergic dermatitis caused by hydroxychloroquine. Contact Dermatitis. 2004;50:255.
Ljunggren B. Psoralen photoallergy caused by plant contact. Contact Dermatitis. 1977;3:85–90.
Lovell C. Phytophotodermatitis. Boca Raton, FL: CRC Press; 2000. p. 51–65.
Lovell C, Cronin E, Rhodes E. Photocontact urticaria from chlorpromazine. Contact Dermatitis. 1986;14:290–1.
Machet L, Vaillant L, Jan V, Lorette G. Fenofibrate-induced photosensitivity: value of photopatch testing. J Am Acad Dermatol. 1997;37:808.
Maciel B, Moreira P, Carmo H, Gonçalo M, Lobo JMS, Almeida IF. Implementation of an in vitro methodology for phototoxicity evaluation in a human keratinocyte cell line. Toxicol In Vitro. 2019;61:104618.
Malani AN, Aronoff DM. Voriconazole-induced photosensitivity. Clin Med Res. 2008;6:83–5.
Mang R, Stege H, Krutmann J. Mechanisms of phototoxic and photoallergic reactions. In: Johansen J, Frosch P, Lepoittevin J-P, editors. Contact dermatitis. Berlin, Heidelberg: Springer-Verlag; 2011. p. 155–63.
Marrot L, Belaïdi J, Jones C, Perez P, Riou L, Sarasin A, et al. Molecular responses to photogenotoxic stress induced by the antibiotic lomefloxacin in human skin cells: from DNA damage to apoptosis. J Invest Dermatol. 2003;121:596–606.
Martin SF. Immunological mechanisms in allergic contact dermatitis. Curr Opin Allergy Clin Immunol. 2015;15:124–30.
Matthieu L, Meuleman L, Van Hecke E, Blondeel A, Dezfoulian B, Constandt L, et al. Contact and photocontact allergy to ketoprofen. The Belgian experience. Contact Dermatitis. 2004;50:238–41.
McCarthy K, Playforf E, Looke D, Whitby M. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy. Clin Infect Dis. 2007;44:e55–6.
Metayer I, Balguerie X, Courville P, Lauret P, Joly P. Photodermatosis induced by hydroxychloroquine: 4 cases. Ann Dermatol Venereol. 2001;128:729.
Miller D, Cowen E, Nguyen J, McCalmont T, Fox L. Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity. Arch Dermatol. 2010;146:300–4.
Moghaddam S, Connolly D. Photo-induced Stevens-Johnson syndrome. J Am Acad Dermatol. 2014;71:e82–3.
Möller H. Contact and photocontact allergy to psoralens. Photodermatol Photoimmunol Photomed. 1990;7:43–4.
Monteagudo-Paz A, Salvador JS, Martinez NL, Granados PA, Martínez PS. Pulpitis as clinical presentation of photoallergic contact dermatitis due to chlorpromazine. Allergy. 2011;66:1503–4.
Monteiro AF, Rato M, Martins C. Drug-induced photosensitivity: photoallergic and phototoxic reactions. Clin Dermatol. 2016;34:571–81.
Morgado F, Calvão J, Barata F, Gonçalo M. Phototoxic reaction to brigatinib—a new photosensitizing drug. J Eur Acad Dermatol Venereol. 2019;33:e491–2.
Morice C, Acher A, Soufir N, Michel M, Comoz F, Leroy D, et al. Multifocal aggressive squamous cell carcinomas induced by prolonged voriconazole therapy: a case report. Case Rep Med. 2010;2010:351084.
Müller L, Kasper P, Kersten B, Zhang J. Photochemical genotoxicity and photochemical carcinogenesis—two sides of a coin? Toxicol Lett. 1998;102–103:383–7.
Munera-Campos M, Castillo G, Ferrándiz C, Carrascosa JM. Actinic lichen planus triggered by drug photosensitivity. Photodermatol Photoimmunol Photomed. 2019;35:124–6.
Murad A, Shudell E, Mulligan N. Rowell’s syndrome induced by terbinafine. BMJ Case Rep. 2015;2015:bcr2015210360.
Neumann N, Holzle E, Lehmann P, Benedikter S, Tapernoux B, Plewig G. Patterns analysis of photopatch test reactions. Photodermatol Photoimmunol Photomed. 1994;16:65–73.
Neumann N, Holzle E, Plewig G, Schwartz T, Pannizzon R, Breit R, et al. Photopatchtesting: the 12-year experience of the German, Austrian and Swiss photopatch test group. J Am Acad Dermatol. 2000;42:183–92.
Neves BM, Cruz MMT, Francisco V, Gonçalo M, Figueiredo A, Duarte CBC, et al. Differential modulation of CXCR4 and CD40 protein levels by skin sensitizers and irritants in the FSCD cell line. Toxicol Lett. 2008;177:74–82.
Oliveira H, Gonçalo M, Figueiredo A. Photosensitivity from lomefloxacine. A clinical and photobiological study. Photodermatol Photoimmunol Photomed. 1996;16:116–20.
Papakonstantinou E, Prasse A, Schacht V, Kapp A, Raap U. Pirfenidone-induced severe phototoxic reaction in a patient with idiopathic lung fibrosis. J EADV. 2016;30:1354–6.
Park M, Shim W, Kim J, Kim G, Kim H, Ko H, et al. Pirfenidone-induced photo-allergic reaction in a patient with idiopathic pulmonary fibrosis. Photodermatol Photoimmunol Photomed. 2017;33:209–12.
Passier A, Smits-van Herwaarden A, van Puijenbroek E. Photo-onycholysis associated with the use of doxycycline. BMJ. 2004;329:265.
Peiser M, Tralau T, Heidler J, Api AM, JHE A, Basketter DA, et al. Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci. 2012;69:763–81.
Pérez N, Esturo S, Viladomiu-Edel A, Moreno A, Valls A. Pseudoporphyria induced by imatinib mesylate. Int J Dermatol. 2014;53:e143–4.
Pérez-Bustillo A, Sánchez-Sambucety P, Suárez-Amor O, Rodríiguez-Prieto M. Torasemide-induced pseudoporphyria. Arch Dermatol. 2008;144:812–3.
Pigatto P, Guzzi G, Schena D, Guarrera M, Foti C, Francalanci S, et al. Photopatch tests: an Italian multicentre study from 2004 to 2006. Contact Dermatitis. 2008;59:103–8.
Placzek M, Eberlein-könig B, Przybilla B. Association between actinic keratoses and potentially photosensitizing drugs. N Engl J Med. 1999;341:1474–5.
Rato M, Gil F, Monteiro AF, Parente J. Fenofibrate photoallergy—relevance of patch and photopatch testing. Contact Dermatitis. 2018;78:413–4.
Ray RS, Mujtaba SF, Dwivedi A, Yadav N, Verma A, Kushwaha HN, et al. Singlet oxygen mediated DNA damage induced phototoxicity by ketoprofen resulting in mitochondrial depolarization and lysosomal destabilization. Toxicology. 2013;314:229–37.
Reddy B, Das S, Udairaj B. Olanzapine-induced photo-allergic reaction. Aust N Z J Psychiatry. 2018;52:807–8.
Redondo V, Vicente J, España A, Subira M, De Filipe I, Quintanilla E. Photo-induced toxic epidermal necrolysis caused by clobazam. Br J Dermatol. 1996;135:999–1002.
Relvas M, Morgado F, Oliveira H, Gonçalo M. Photosensitivity as the presenting feature of human immunodeficiency virus infection. Rev SPDV. 2020;78:3.
Riahi R, Cohen P. Voriconazole-associated phototoxicity. Dermatol Online J. 2011;17:15.
Rinderknecht JD, Goldinger SM, Rozati S, Kamarashev J, Kerl K, French LE, et al. RASopathic skin eruptions during vemurafenib therapy. PloS One. 2013;8:e58721.
Rodriguez-Pazos L, Sanchez-Aguilar D, Rodriguez-Granados MT, Pereiro-Ferreiros MM, Toribio J. Erythema multiforme photoinduced by statins. Photodermatol Photoimmunol Photomed [Internet]. 2010;26:216–8. https://doi.org/10.1111/j.1600-0781.2010.00519.x.
Rodríguez-Pazos L, Gómez-Bernal S, Rodríguez-Granados MT, Toribio J. Photodistributed erythema multiforme. Actas Dermosifiliogr. 2013;104:645–53.
Rok J, Buszman E, Beberok A, Delijewski M, Otręba M, Wrześniok D. Modulation of melanogenesis and antioxidant status of melanocytes in response to phototoxic action of doxycycline. Photochem Photobiol. 2015;91:1429–34.
Rosenthal A, Herrmann J. Hydrochlorothiazide-induced photosensitivity in a psoriasis patient following exposure to narrow-band ultraviolet B excimer therapy. Photodermatol Photoimmunol Photomed. 2019;35:369–71.
Sánchez-Pérez J, Sanz Sánchez T, García-Diez A. Combined contact and photocontact allergic dermatitis to etofenamate in Flogoprofen gel. Am J Contact Dermat. 2001;12:215–6.
Santo Domingo D, Stevenson M, Auerbach J, Lerman J. Finasteride-induced pseudoporphyria. Arch Dermatol. 2011;147:747–8.
Sanz-Motilva V, Martorell-Calatayud A, Llombart B, Requena C, Serra-Guillén C, Nagore E, Guillén C, V. Traves OS. Sunitinib-induced pseudoporphyria. J Eur Acad Dermatol Venereol. 2015;29:1848–50.
Schauder S, Schroder W, Geier J. Olaquindox-induced airborne photoallergic contact dermatitis followed by transient or persistent light reactions in 15 pig breeders. Contact Dermatitis. 1996;35:344–54.
Scherschun L, Lee MW, Lim HW. Diltiazem-associated photodistributed hyperpigmentation: a review of 4 cases. Arch Dermatol. 2001;137:179.
Schmutz J-L, Barbaud A, Tréchot P. Pseudoporphyria and coxib. Ann Dermatol Vénéreol. 2006;133:213.
Schmutz J-L, Barbaud A, Tréchot P. Ciprofloxacin and pseudoporphyria. Ann Dermatol Vénéreol. 2008;135:804.
Serra D, Gonçalo M, Figueiredo A. Two decades of cutaneous adverse drug reactions from piroxicam. Contact Dermatitis. 2008;58:35.
Seto Y, Ochi M, Onoue S, Yamada S. High-throughput screening strategy for photogenotoxic potential of pharmaceuticalsubstances using fluorescent intercalating dye. J Pharm Biomed Anal. 2010;52:781–6.
Shah RA, Bennett DD, Burkard ME. Photosensitive lichenoid skin reaction to capecitabine. BMC Cancer. 2017;17:866.
Sheu J, Hawryluk EB, Guo D, London WB, Huang JT. Voriconazole phototoxicity in children: a retrospective review. J Am Acad Dermatol. 2015;72:314–20.
Shin D, Lee ES, Kim J, Guerra L, Naik D, Prida X. Association between the use of thiazide diuretics and the risk of skin cancers: a meta-analysis of observational studies. J Clin Med Res. 2019;11:247–55.
Siiskonen SJ, Koomen ER, Visser LE, Herings RMC, Guchelaar HJ, Stricker BHC, et al. Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma. Eur J Clin Pharmacol. 2013;69:1437–44.
Simpson CL, McCausland D, Chu EY. Photo-distributed lichenoid eruption secondary to direct anti-viral therapy for hepatitis C. J Cutan Pathol. 2015;42:769–73.
Singh LK, SKP MS. Olanzapine-induced reversible pellagroid skin lesion. Curr Drug Saf. 2015;10:251–3.
Sontheimer R, Henderson C, Grau R. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res. 2008;301:65–70.
Stern R. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet a therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66:553–62.
Stingeni L, Foti C, Cassano N, Bonamonte D, Vonella M, Vena G, et al. Photocontact allergy to arylpropionic acid non-steroidal anti-inflammatory drugs in patients sensitized to fragrance mix I. Contact Dermatitis. 2010;63:108–10.
Sugiura M, Hayakawa R, Kato Y, Sugiura K, Ueda H. 4 cases of photocontact dermatitis due to ketoprofen. Contact Dermatitis. 2000;43:16–9.
Susong J, Carrizales S. Lichenoid photosensitivity: an unusual reaction to doxycycline and an unusual response. Cutis. 2014;93:E1.
Timmer-de Mik L, Kardaun S, Krammer M, Hayes D, Bousema M. Imatinib-induced pseudoporphyria. Clin Exp Dermatol. 2009;34:705–7.
Tokunaga M, Iga N, Endo Y, Fujisawa A, Tanioka M, Kabashima K, et al. Elevated protoporphyrin in patients with skin cancer receiving taxane chemotherapy. Eur J Dermatol. 2013;23:826–9.
Tolland J, McKeown P, Corbett J. Voriconazole-induced pseudoporphyria. Photodermatol Photoimmunol Photomed. 2007;23:29–31.
Traianou A, Ulrich M, Apalla Z, De Vries E, Bakirtzi K, Kalabalikis D, et al. Risk factors for actinic keratosis in eight European centres: a case-control study. Br J Dermatol. 2012;167:36–42.
Trujillo M, Barrio M, Rodríguez A, Moreno-Zazo M, Sánchez I, Pelta R, et al. Piroxicam-induced photodermatitis. Cross-reactivity among oxicams. A case report. Allerg Immunol. 2001;29:133–6.
Tsai K, Yang J, Hung S. Fenofibrate-induced photosensitivity—a case series and literature review. Photodermatol Photoimmunol Photomed. 2017;33:213–9.
Tsuruta A, Washio K, Fukunaga A, Nishigori C. Pirfenidone-induced photoleukomelanoderma in a patient with idiopathic pulmonary fibrosis. J Dermatol. 2016;43:207.
Udompanich S, Chanprapaph K, Rajatanavin N. Phototoxic reaction induced by Pazopanib. Case Rep Dermatol. 2018;10:251–6.
Urbach F. Phototoxicity and possible enhancement of photocarcinogenesis by fluorinated quinolone antibiotics. J Photochem Photobiol B. 1997;37:169–70.
Urbina F, Barrios M, Sudy E. Photolocalized purpura during ciprofloxacin therapy. Photodermatol Photoimmunol Photomed. 2006;22:111–2.
Vaccaro M, Borgia F, Barbuzza O, Guarneri B. Photodistributed eruptive telangiectasia: an uncommon adverse drug reaction to venlafaxine. Br J Dermatol. 2007;157:822–4.
Varela P, Amorim I, Massa A, Sanches M, Silva E. Piroxicam-beta-cyclodextrin and photosensitivity reactions. Contact Dermatitis. 1998;38:229.
Vassileva S, Matev G, Parish L. Antimicrobial photosensitive reactions. Arch Intern Med. 1998;158:1993–2000.
Verma R, Vasudevan B, Shankar S, Pragasam V, Suwal B, Venugopal R, et al. First reported case of tenofovir-induced photoallergic reaction. Indian J Pharm. 2012;44:651.
Veyrac G, Paulin M, Milpied B, Bourin M, Jolliet P. Bilan de l’enquête nationale sur les effets indésirables cutanés do kétoprofène gel enregistrés entre le 01/09/1996 et le 31/08/2000. Therapie. 2002;57:55–64.
Vilaplana J, Romaguera C, Azón A, Lecha M. Flutamide photosensitivity-residual vitiliginous lesions. Contact Dermatitis. 1990;38:68–70.
Walker S, Ead R, Beck M. Occupational photoallergic contact dermatitis in a pharmaceutical worker manufacturing carprofen, a canine nonsteroidal anti-inflammatory drug. Br J Dermatol. 2006;154:551–77.
Walker G, Lane N, Parekh P. Photosensitive lichenoid drug eruption to capecitabine. J Am Acad Dermatol. 2014;71:e52–3.
Watanabe T, Hgaki H, Yamada N, Yoshida Y, Yamamoto O. Photoallergic contact dermatitis in a pig farmer, caused by cotrimoxazole. Eur J Dermatol. 2009;19:526–7.
Williams K, Mansh M, Chin-Hong P, Singer J, Arron ST. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients. Clin Infect Dis. 2014;58:997–1002.
Wlodek C, Narayan S. A reminder about photo-onycholysis induced by tetracycline, and the first report of a case induced by lymecycline. Clin Exp Dermatol. 2014;39:746–7.
Woods JA, Ferguson JS, Kalra S, Degabriele A, Gardner J, Logan P, et al. The phototoxicity of vemurafenib: an investigation of clinical monochromator phototesting and in vitro phototoxicity testing. J Photochem Photobiol B Biol. 2015;151:233–8.
Yanovsky RL, Bartenstein DW, Rogers GS, Isakoff SJ, Chen ST. Photodynamic therapy for solid tumors: a review of the literature. Photodermatol Photoimmunol Photomed. 2019;35:295–303.
Yazici A, Baz K, Ikizoglu G, Kokturk A, Uzumlu H, Tataroglu C. Celecoxib-induced photoallergic drug eruption. Int J Dermatol. 2004;43:459–61.
Yokote R, Tokura Y, Igarashi N, Ishikawa O, Miyachi Y. Photosensitive drug eruption induced by flutamide. Eur J Dermatol. 1998;8:427.
Yones SS, O’Donoghue NB, Palmer RA, Menage Hdu P, Hawk JL. Persistent severe amiodarone-induced photosensitivity. Clin Exp Dermatol. 2005;30:500–2.
Yoshimoto E, Konishi M, Takahashi K, Murukawa K, Maeda K, Mikasa K, et al. The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection. Intern Med. 2004;43:630–1.
Youn J, Lee H, Yeo U, Lee Y. Piroxicam photosensitivity associated with vesicular hand dermatitis. Clin Exp Dermatol. 1993;18:52–4.
Zaheer MR, Gupta A, Iqbal J, Zia Q, Ahmad A, Roohi, et al. Molecular mechanisms of drug photodegradation and photosensitization. Curr Pharm Des. 2016;22:768–82.
Zeuzem S, Soriano V, Asselah T, Bronowicki J-P, Lohse AW, Müllhaupt B, et al. Faldaprevir and deleobuvir for HCV genotype 1 infection. N Engl J Med. 2013;369:630–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gonçalo, M., Giménez-Arnau, A. (2023). Drug Photosensitivity. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_23
Download citation
DOI: https://doi.org/10.1007/978-3-031-15130-9_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15129-3
Online ISBN: 978-3-031-15130-9
eBook Packages: MedicineMedicine (R0)